All lobbying filings

Buchanan Ingersoll & Rooney PC

Buchanan Ingersoll & Rooney PC filed a Q2 report for Bioflorida, Inc. on July 20, 2026, reporting $20,000 in lobbying income.

Lobbying for Bioflorida, Inc. · Life sciences organization

As filed: BUCHANAN INGERSOLL & ROONEY PC for BIOFLORIDA, INC.

All filings by Buchanan Ingersoll & Rooney PC · Everything Bioflorida, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Florida

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 7

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Budget/Appropriations

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Copyright/Patent/Trademark

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Medical/Disease Research/Clinical Labs

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Medicare/Medicaid

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem